EXXT:XETRA:XETRA-iShares NASDAQ-100® UCITS ETF (DE) EUR (EUR)

ETF | Others |

Last Closing

USD 173.44

Change

-1.04 (-0.60)%

Market Cap

USD 4.15B

Volume

0.07M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.41 (+0.79%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.13 (+0.77%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.97%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.21 (+0.73%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.10 (+0.41%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.01%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.01%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.40 (+0.78%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.19 (+0.20%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.48 (+0.27%)

USD 80.38B

ETFs Containing EXXT:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.65% 79% B- 77% C+
Dividend Return 0.27% 7% C- 4% F
Total Return 16.93% 79% B- 77% C+
Trailing 12 Months  
Capital Gain 27.89% 80% B- 79% B-
Dividend Return 0.30% 7% C- 4% F
Total Return 28.19% 80% B- 79% B-
Trailing 5 Years  
Capital Gain 158.60% 99% N/A 96% N/A
Dividend Return 1.45% 15% F 8% B-
Total Return 160.04% 99% N/A 96% N/A
Average Annual (5 Year Horizon)  
Capital Gain 20.50% N/A N/A 90% A-
Dividend Return 20.65% N/A N/A 90% A-
Total Return 0.15% N/A N/A 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 20.83% N/A N/A 30% F
Risk Adjusted Return 99.14% N/A N/A 95% A
Market Capitalization 4.15B 94% A 84% B

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike